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We discovered a class of naturally occurring human
proteins with unusually high net positive charge
that can potently deliver proteins in functional form
into mammalian cells both in vitro and also in murine
retina, pancreas, and white adipose tissues in vivo.
These findings represent diverse macromolecule
delivery agents for in vivo applications, and also raise
the possibility that some of these human proteins
may penetrate cells as part of their native biological
functions.
INTRODUCTION
Macromolecules serve as essential research tools and important
human therapeutics, but are limited by their general inability to
cross cell membranes. Previously, we discovered that engi-
neered green fluorescent protein (GFP) variants with a very high
net positive charge canpotently penetrate anddeliver associated
macromolecules into mammalian cells (Cronican et al., 2010;
McNaughton et al., 2009). Since these ‘‘supercharged’’ GFPs
were engineered to maximize net charge (Lawrence et al.,
2007), we hypothesized that naturally occurring human proteins
with a high net positive charge may possess undiscovered cell-
penetrating properties. Identifying such a class of proteins would
enable many proteins with varying charge, structure, and molec-
ularweight to beusedas newagents for thedelivery ofmacromo-
lecular cargo into mammalian cells and would also raise the
possibility that these proteins may possess native biological
functions associated with their ability to penetrate cells.
RESULTS
Identification of Naturally Supercharged Human
Proteins
To identify naturally supercharged human proteins (NSHPs), we
ranked all proteins within the human proteome by their net theo-
retical charge to molecular weight ratio. Based on our previousChemistry & Biology 18,cell-penetration results with +15, +25, and +36 GFPs (McNaugh-
ton et al., 2009), we hypothesized that proteins with a ratio of
charge units per kDa greater than 0.75 could be potent cell-
penetrating proteins. Of the 13,417 human proteins with
evidence of existence at the protein level in the Swiss-Prot data-
base, 309 entries (2.3%) possess a +charge:mw ratio > 0.75, and
104 (0.8%) have a ratio equal to or greater than that of +36 GFP
(+1.27/kD). To facilitate expression of the human proteins in
E. coli, we performed the same analysis on human proteins
within the RSCB Protein Data Bank (PDB) that were expressed
in E. coli and chose seven unrelated examples from this list:
b-defensin 3, HRX, c-Jun bZIP domain, eotaxin 3, HBEGF,
N-DEK, and N-HGF (Figure 1A). b-defensin 3 is an extracellular
antimicrobial protein (see Table S1A available online) (Harder
et al., 2001). HRX, c-Jun, and N-DEK are nuclear proteins known
to interact with DNA (Glover and Harrison, 1995; Hollenbach
et al., 2002; Nakamura et al., 2002). HBEGF and N-HGF are
extracellular growth factors (Cioce et al., 1996; Elenius et al.,
1997), and eotaxin 3 is a chemotactic protein (Shinkai et al.,
1999). We purified these proteins as fusions with the red fluores-
cent protein mCherry. Eotaxin 3-mCherry did not express to
appreciable levels. We incubated the remaining fusions with
HeLa, 3T3, and BSR cells in vitro for 4 hr and then washed the
cells with heparin PBS to remove all membrane-bound protein
(Figure S1C). We observed that all six NSHP-mCherry fusions
potently penetrated all three cell lines both by live-cell fluores-
cence microscopy (Figure S1D) and by flow cytometry (Fig-
ure 1B). The NSHPs deliveredmCherry with up to 40-fold greater
efficiency than standard protein transduction domains (PTDs),
including Tat, Arg10, and penetratin. Internalization of all of the
NSHP-mCherry fusions tested, but not internalization of trans-
ferrin-Alexa Fluor 568, was inhibited by +36 GFP (Figure 1C),
indicating that the NSHPs penetrate cells by a mechanism
competitive with that of +36 GFP. We also selected a larger
protein (NEIL1 endonuclease, 40.9 kDa) with high net theoretical
charge but lower charge to molecular weight ratio and observed
that, when enzymatically biotinylated, NEIL1 delivers noncova-
lently associated streptavidin into BSR cells at high nM concen-
trations (Figure S1H). Taken together, these results suggest that
many naturally supercharged human proteins possess the ability
to potently penetrate mammalian cells.833–838, July 29, 2011 ª2011 Elsevier Ltd All rights reserved 833
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Figure 1. Naturally Supercharged Human Proteins Penetrate Mammalian Cells In Vitro
(A) Plot of human proteins expressed from E. coli within the Protein Data Bank. The blue dots represent proteins with positive charge:molecular weight ratios
exceeding +0.75/kDa.
(B) Median mCherry fluorescence of HeLa, 3T3, and BSR cells incubated with NSHP-mCherry fusions as measured by flow cytometry.
(C) NSHP-mCherry fusions (300 nM) were incubated with HeLa cells for 4 hr with increasing concentrations of +36 GFP. After incubation, cells were washed with
heparin PBS, and internalized NSHP-mCherry was quantified by flow cytometry. For each fusion protein, the percentage of mCherry fluorescence relative to the
mCherry intensity without +36 GFP is shown. The coincubation experiment was also performed with 10 mg/ml transferrin-Alexa568 (shown in black), which is
internalized through an independent mechanism.
See also Figure S1.
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Naturally Supercharged Human ProteinsFunctional Protein Delivery into Mammalian
Cells In Vitro
To test the ability of NSHPs to deliver functional protein outside
of endosomes, we generated Cre recombinase fusions to six
NSHPs (HRX, c-Jun bZIP domain, eotaxin 3, HBEGF, N-DEK,
and N-HGF) (Figure S2). Functional Cre delivery requires inter-
nalization of Cre, localization to the nucleus, tetramerization,
and site-specific DNA recombination to activate reporter gene
expression. We incubated the six NSHP-Cre fusion proteins
with floxed tdTomato BSR cells, and again in all six cases,
observed expression of the tdTomato reporter gene both by
live-cell fluorescence microscopy (Figure 2A) and by flow
cytometry (Figure 2B). For three of the human proteins (c-Jun,
HBEGF, and N-DEK), the efficiency of functional Cre delivery
at concentrations below 1 mM was higher than that of Arg10
and penetratin, and comparable to that of Tat. These pro-
teins were not toxic to cultured BSR cells (Figure S2D). Collec-
tively, these results demonstrate that a diverse set of proteins
within the human proteome can potently deliver functional
protein into mammalian cells, some of which is able to escape
endosomes.834 Chemistry & Biology 18, 833–838, July 29, 2011 ª2011 Elsevier LFunctional ProteinDelivery intoMammalianCells In Vivo
We next sought to determine if this class of proteins could serve
as a natural platform for the delivery of macromolecular cargo in-
vivo. The direct delivery of functional protein into cells in vivo is of
special interest because of the rarity of successful in vivo protein
transduction examples (Caron et al., 2001; Ja¨rver et al., 2010),
the clinical need for protein-delivery agents (Chen and Cepko,
2009; Seale et al., 2007; Zhou et al., 2008), and the drawbacks
associated with alternative methods such as viral infection
(Atkinson and Chalmers, 2010). We therefore tested the ability
of NSHPs to deliver functional protein in vivo in adult mice in
three tissues of current therapeutic interest: the retina (Chen
and Cepko, 2009), pancreas (Zhou et al., 2008), and white
adipose tissues (Seale et al., 2007). Cre fusions of three NSHPs
(c-Jun, HBEGF, and N-DEK) along with Cre, Tat-Cre, +36 GFP-
Cre, Cre expressing adenovirus were injected subretinally into
floxed LacZ mice (n = 4). Retinae were harvested three days
postinjection, and the NSHP-Cre-injected retinae were found
to possess large patches of recombined cells. In contrast,
retinae injected with wild-type Cre did not possess significant
populations of recombined cells (Figure 3A; Figure S3A).td All rights reserved
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Figure 2. Naturally Supercharged Human Proteins Deliver Active Protein into Mammalian Cells In Vitro
(A) Live-cell fluorescence microscopy of floxed tdTomato BSR cells two days after incubation for 4 hr with 2 mM NSHP-Cre fusions. The scale bar is 200 mm.
(B) Percent recombined cells among floxed tdTomato BSR cells incubated with NSHP-Cre fusions as measured by flow cytometry.
See also Figure S2.
Chemistry & Biology
Naturally Supercharged Human ProteinsCryosections of these retinae indicated labeling of Mu¨ller glia
cells as well as other cell types, including cells of hematopoetic
origin (Figure 3B). The same set of three NHSP-Cre fusions were
individually injected directly into the pancreas of floxed LacZ
mice (n = 3 for quantification; n = 1 for imaging). The pancreases
were harvested five days postinjection and the NSHP-Cre-
injected pancreases were found to possess up to 6-fold more
LacZ+ cells than wild-type Cre-injected pancreases by immu-
nostaining and enzymatic assay (Figure 3C). Finally, the same
suite of Cre proteins were injected subcutaneously into the
abdomens of floxed luciferase mice (n = 4). The white adipose
tissues of these mice were harvested three days postinjection,
imaged, and assayed for luciferase activity, and the NSHP-Cre
injected mice were found to possess up to 125-fold more lumi-
nescence in their white adipose tissue over the white adipose
tissues of mice injected with wild-type Cre (Figure 3D; Fig-
ure S3B). To our knowledge, these results represent the first
functional protein delivery into cells of white adipose tissue
in vivo. Although these three examples involve local injections
of supercharged proteins, we note that +36 GFP is able to circu-
late intravenously (Figure S3C), and five of the eight human
proteins tested in this study are known to be naturally secreted
proteins (Table S1A), suggesting that theymay represent vectors
compatible with systemic protein delivery in vivo. These results
collectively establish that NSHPs can deliver functional protein
into cells of a variety of mammalian tissues in vivo. For delivery
to retinal cells and white adipose tissue, at least one NSHP
was more effective at delivering active Cre than two of the
most widely used current protein delivery methods, fusion with
Tat peptide, or infection with adenovirus (Figures 3A and 3D).
DISCUSSION
Our previous work with engineered supercharged proteins led us
in the present study to identify a class of hundreds of naturally
occurring supercharged human proteins within the human pro-
teome that possess net theoretical charge:molecular weight
ratios similar to that of +36 GFP. All eight tested NSHPs selected
from the PDB were observed to penetrate mammalian cells and
deliver covalently or noncovalently associated protein, despite
their diverse structures and known functions. It is generallyChemistry & Biology 18,accepted that positively charged peptides, polymers, and lipo-
somes are able to penetrate mammalian cells (Nakase et al.,
2008). Cationic peptides, however, have been reported to
possess maximal cell-penetration potency with 8–15 positively
charged amino acids and are inhibited by additional positively
charged amino acids (Futaki et al., 2001; Mitchell et al., 2000).
Our results suggest that even small proteins (5.2–15.1 kDa)
that possess up to 31 positively charged amino acids behave
differently than cationic peptides and exhibit cell-penetration
and macromolecule-delivery capabilities that are not inhibited
by their high charge magnitude. The unusual potency of NSHPs
compared with cationic peptides may arise from differences in
charge density, structure, or surface area. These results also
suggest that the potent macromolecule delivery properties of
supercharged GFPs are not limited to a small number of engi-
neered proteins, but instead are present among many different
protein structures and folds, including proteins of much lower
net theoretical charge magnitude (+10–+19).
Previous bioinformatic methods have identified minimal cell-
penetrating peptides within human proteins by searching for
densely cationic regions of the protein sequence (Futaki et al.,
2003; Hansen et al., 2008). In contrast, the proteins examined
in the current study possess positively charged amino acids
widely dispersed throughout their sequence, and would not
have been identified using these previously reported methods.
Moreover, the NSHPs we have identified were able to mediate
internalization of fused proteins with up to 40-fold higher potency
than commonly used cell-penetrating peptides. Thus, NSHPs
are not only structurally distinct from most peptide-based pro-
tein delivery reagents, but are also functionally distinct, medi-
ating internalization of fused protein with significantly greater
potency for some applications. A 28-amino acid peptide from
the bZIP domain of c-Jun had previously been identified as
cell-penetrating based upon its known biological role of binding
to DNA (Futaki et al., 2001). HBEGF has also been used to deliver
protein into mammalian cells based upon its known affinity for
epidermal growth factor receptors (Chandler et al., 1998). Our
method was able to positively identify these cell-penetrating
proteins based solely on their amino acid sequence.
Our findings also raise the possibility that NSHPs may play
biological roles that arise from their ability to penetrate cells833–838, July 29, 2011 ª2011 Elsevier Ltd All rights reserved 835
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Figure 3. Naturally Supercharged Human Proteins Deliver Active Proteins into Three Adult Murine Tissues In Vivo
(A) Adult floxed LacZ mice were injected subretinally with Cre fusion proteins. Recombination results in LacZ activity, which was visualized with X-gal stain (blue)
three days after injection.
(B) Sections of recombined retinae from the samples in (A) reveal that most of the recombination signal arises from Mu¨ller glial cells.
(C) Adult floxed LacZ mice injected in the pancreas with Cre fusion proteins exhibit recombination in the exocrine tissues as indicated by LacZ immunostaining
(red) and LacZ activity assay five days postinjection.
(D) Adult floxed luciferase mice injected subcutaneously with Cre fusion proteins exhibit recombination in the white adipose tissue as visualized by luminescence
and luciferase activity assay three days postinjection.
For (A) and (D), representative results are shown; see Figure S3 for data from additional replicates.
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Naturally Supercharged Human Proteinsbut are currently unknown. For example, DEK was recently re-
ported to be secreted by macrophage upon stimulation with
interleukin-8 (Mor-Vaknin et al., 2006), a curious finding for
a nuclear protein thought to be involved in chromatin remodel-
ing. Our discovery that N-DEK can potently penetrate cells and
escape endosomes as a fusion protein in vivo suggests that
DEK may possess an intracellular function within target cells.
Considering the large number of proteins within the NSHP class
as well as known cases in which secreted proteins have been
shown to exhibit intracellular activity (Brunet et al., 2005; Frankel
and Pabo, 1988; Green and Loewenstein, 1988; Joliot et al.,
1991; Lo¨fgren et al., 2008; Mallery et al., 2010), the possibility836 Chemistry & Biology 18, 833–838, July 29, 2011 ª2011 Elsevier Lthat someNSHPsmay enter cells as part of their native functions
merits further study.
SIGNIFICANCE
Our results reveal that potent vehicles for macromolecule
delivery into mammalian cells in vivo already exist within
the human body in the form of naturally supercharged pro-
teins. The fact that the set of NSHPs tested include several
secreted circulating human proteins (Table S1) suggests
that they could serve as a new set of biologic delivery agents
with a diversity of important properties such as charge,td All rights reserved
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Naturally Supercharged Human Proteinsstructure, molecular weight, immunogenicity, stability, and
in vivo half-life. Moreover, the ability of virtually all NHSPs
to penetrate cells has not been previously reported (Chan-
dler et al., 1998; Futaki et al., 2003; Kaouass et al., 2006;
Rosenbluh et al., 2005). Our findings are consistent with
the intriguing possibility that members of this substantial
class of natural proteins may play undiscovered biological
roles that arise from their ability to penetrate cells.
EXPERIMENTAL PROCEDURES
Identification of Naturally Supercharged Human Proteins
To identify naturally supercharged human proteins amenable to recombinant
expression in E. coli, the Research Collaboratory for Structural Bioinformatics
Protein Data Bank (RCSB PDB, http://www.rcsb.org) was filtered for PDB IDs
of proteins with source organism (Homo sapiens) and expression organism
(Escherichia coli). Approximately 10,000 unique PDB IDsmatched both criteria
and were downloaded as FASTA files. The primary sequence of each chain
within each PDB ID was used to calculate net theoretical charge (lysine and
arginine: +1; aspartate and glutamate:1) andmolecular weight. The resulting
data was compiled into one text file using a Python script.
To estimate the prevalence of naturally supercharged human proteins within
the entire human proteome, the same analysis was performed on human
proteins with evidence of existence at the protein level within the Swiss-Prot
database (http://www.uniprot.org/).
Additional experimental procedures can be found in the Supplemental
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, one table, Supplemental
Experimental Procedures, and Supplemental Sequences and can be found
with this article online at doi:10.1016/j.chembiol.2011.07.003.
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